Outlook
Group and segment outlook 2024
Fresenius upgrades its outlook for FY/241. Based on the excellent first nine months of 2024, Group organic revenue growth2,4,5 is now expected to grow between 6% to 8% (previous: between 4% to 7%) in 2024 and Group constant currency EBIT3,4 is anticipated to grow in a 8% to 11% range (previous: between 6% to 10%).
Fresenius Kabi expects organic revenue growth5 in a mid-to high-single-digit percentage range in 2024. The EBIT margin4 is expected to be in a range of 15% to 16% (structural margin band: 14% to 17%).
Fresenius Helios expects organic revenue4 to grow in mid-single digit percentage range in 2024. The EBIT margin4 is expected to be within 10% to 11% (structural margin band: 10% to 12%).
The Group outlook is given without Fresenius Vamed, i.e. exclusively for the Operating Companies Fresenius Kabi and Fresenius Helios.
1 For the prior-year basis please see table “Basis for Guidance for 2024"
2 2023 base: €20,307 million
3 2023 base: €2,266 million
4 Before special items
5 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation
| Fiscal year 2023 (base)2 | Targets 2024 | |
|---|---|---|
Fresenius Group | ||
Revenue growth (organic) | €20,307 m | 6–8% |
EBIT growth1 (in constant currency) | €2,266 m | 8–11% |
Operating Companies | ||
Fresenius Kabi | ||
Revenue growth (organic) | €8,009 m | Mid-to high-single-digit percentage range |
EBIT margin1 | €1,145 m | In a range of 15% to 16% (structural margin band: 14-17%) |
Fresenius Helios | ||
Revenue growth (organic) | €11,952 m | Mid-single-digit percentage growth |
EBIT margin1 | €1,190 | 10% – 11% (structural margin band: 9 – 11%) |
-
1 Before special items
As of Nov 6, 2024
Related Links
Interactive Tool